113 
DR. HANDLER: Be careful about how you denigrate industry. 
DR. BALTIMORE: I said I was trying to be gentle, but I don't think we 
are looking at an adversary situation in which it is the scientists against 
the public or the scientists trying to grab for something for themselves. I 
really think — in fact, I am absolutely sure — that especially in the formula- 
tion of these guidelines, you have seen scientists at work trying to do what 
they felt was right for the public, not right for themselves. Right for 
themselves was very clear. It would have been to shut up as soon as you re- 
alized there was a problem if all you wanted to do was get on with your work. 
What you have seen here is an historic process by which everybody in 
the community has not shut up but, in fact, has been mulling it over in 
their minds, talking about it, working it out, meeting in committees, taking 
a very large amount of their time. 
DR. FREDRICKSON: Thank you, Dr. Baltimore. 
I am going to call now on Dr. Charles Madansky from Harvard, and fol- 
lowing Dr. Madansky' s statement and discussion, we will then have a short 
coffee break. 
Dr. Madansky, would you tell us your affiliation at Harvard? 
MR. MADANSKY: First thing, I am not a doctor yet. I am a graduate 
student. 
DR. FREDRICKSON: That's all right, we are all in this together. 
(Laughter. ) 
MR. MADANSKY: I am doing research on the genetics of an animal virus 
at the University of Massachusetts Medical School. I am actually a graduate 
student in the Department of Microbiology and Molecular Genetics at Harvard 
Medical School. 
And I am here because I am sincerely concerned over the potential haz- 
ards involved in the use of DNA recombinant technology as regulated in the 
present set of proposed guidelines, and what I say now represents as well 
the opinions of many concerned scientists, including the Boston Area Recom- 
binant DNA Group, and the Genetics and Social Policy Group of Science for 
the People. 
The long and difficult job of drafting these guidelines was a truly ad- 
mirable endeavor. As someone who comes in daily contact with people doing 
this type of research, I feel very strongly that now is the best time to im- 
prove and tighten these guidelines in spite of the growing impatience of in- 
dustry and certain researchers to get on with the work. 
[254] 
